4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
Holding FDMT?
Track your performance easily

4D Molecular Therapeutics (FDMT) Financial Statements

280 Followers

4D Molecular Therapeutics Financial Overview

4D Molecular Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.734; its P/E ratio is -2.96; 4D Molecular Therapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 5.00K$ 28.00K$ -18.00K$ 20.20M$ 239.00K
Gross Profit$ 5.00K$ 28.00K$ -18.00K$ 20.20M$ 239.00K
EBIT$ -34.95M$ -32.40M$ -32.28M$ -10.26M$ -29.62M
EBITDA$ -32.57M$ -31.56M$ -31.25M-$ -28.41M
Net Income Common Stockholders$ -34.95M$ -32.40M$ -32.28M$ -10.26M$ -29.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 541.95M$ 525.91M$ 288.23M$ 319.66M$ 310.34M
Total Assets$ 620.12M$ 629.88M$ 339.89M$ 361.61M$ 352.50M
Total Debt$ 13.66M$ 14.17M$ 14.67M$ 15.16M$ 15.63M
Net Debt$ -528.29M$ -511.74M$ -273.56M$ -304.51M$ -294.71M
Total Liabilities$ 31.78M$ 29.32M$ 32.06M$ 31.68M$ 27.36M
Stockholders Equity$ 588.32M$ 600.56M$ 307.83M$ 329.93M$ 325.13M
Cash Flow-
Free Cash Flow$ -30.59M$ -29.80M$ -25.20M-$ -22.87M
Operating Cash Flow$ -30.24M$ -29.09M$ -24.65M$ -1.17M$ -22.07M
Investing Cash Flow$ -73.54M$ -263.26M$ -6.68M$ 29.98M$ 49.29M
Financing Cash Flow$ 17.25M$ 318.83M$ 4.76M$ 10.56M$ 130.52M
Currency in USD

4D Molecular Therapeutics Earnings and Revenue History

4D Molecular Therapeutics Debt to Assets

4D Molecular Therapeutics Cash Flow

4D Molecular Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis